Funding Opportunities

We offer an array of funding opportunities that support our mission of turning research observations into health solutions through translational science.

Open Funding Opportunities

Find an open funding opportunity using the search tool. The expiration date currently displayed is the final expiration date.

Learn more about the NIH clinical trial requirements for grants and contracts.

If you are looking for closed opportunities, visit grants.nih.gov.

Investigators may apply for NIH-funded scientific conference grants to support high-quality national and international meetings that are relevant to public health and our mission. See NIH’s frequently asked questions for more information.

Name	NCATS Issued	FOA Number	Activity Code	Posting Date	Expiration Date	Opportunity Type
Request for Information (RFI) on the Proposed Funding Priorities for Neuroscience Research, Input on Cross-Cutting Opportunities (NIH Neuroscience Blueprint)	✘	NOT-NS-19-002		10/17/2018		NA
Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NCATS Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44) Funding Opportunity Announcement	✔	NOT-TR-19-004		10/15/2018		NA
Notice of Intent to Publish a Funding Opportunity Announcement for Tissue Chips to Model Nociception, Addiction, and Overdose (UG3/UH3 Clinical Trial Not Allowed)	✔	NOT-TR-19-007		10/15/2018		NA
Notice of Availability of Administrative Supplements for Tissue Chip Consortium Awardees: Development of Tissue Chips to Model Nociception, Opioid Addiction and Overdose	✔	NOT-TR-18-027		07/27/2018		NA
Notice of Pre-Submission Webinars for RFA-TR-18-020: Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) and RFA-TR-18-021: Data Management and Coordinating Center (DMCC)	✔	NOT-TR-18-029		06/19/2018		NA
Notice to update Application Types Allowed for PAR-18-464: Clinical and Translational Science Award (U54 Clinical Trial Optional)	✔	NOT-TR-18-028		06/11/2018		NA
Notice of NCATS Participation in RFA-HL-19-018 NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 - Clinical Trial Optional)	✔	NOT-TR-18-026		05/16/2018		NA
National Center for Advancing Translational Sciences (NCATS) Policy for Support of Phase III Clinical Trial Activities for a Rare Disease or Condition	✔	NOT-TR-18-025		05/09/2018		NA
Notice of Change of Application Due Date to PAR-18-245 "Limited Competition: Exploratory CTSA Collaborative Innovation Awards (R21)"	✔	NOT-TR-18-024		04/23/2018		NA
Notice of Change to Application Due Date to PAR-18-244 "Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01)"	✔	NOT-TR-18-023		04/23/2018		NA

Last updated on February 11, 2026